Friday, July 30, 2021

New relevant target for PARP inhibitor talazoparib

Researchers report the identification of a new target for the PARP inhibitor drug talazoparib and show that combination treatment with talazoparib and the WEE1 inhibitor adavosertib results in enhanced anti-cancer effects.

from Top Health News -- ScienceDaily https://ift.tt/3fgDUXo
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

They fled the flames—now jaguars rule a wetland refuge

After devastating wildfires scorched the Brazilian Pantanal, an unexpected phenomenon unfolded—more jaguars began arriving at a remote wetla...